Micro-Helix is a biotechnology startup founded in 2014 that aims to enhance medical accuracy and precision in infection cures through advanced genetic testing and biological information analysis. The company offers genetic testing and biological information analysis services to healthcare facilities in the Biotechnology and Health Care industries, serving as a crucial support system for medical institutions, scientific research organizations, and businesses.
The most recent investment in Micro-Helix was a CNY10.00M Series A round, which took place on 29th August 2016. The investors in this round included Elite Capital, NCE Ventures, Golden Sunflower Capital, and Touhu Network.
The focus of Micro-Helix on advanced genetic testing and bioinformatics analysis showcases its commitment to leveraging cutting-edge technology for promoting precision medicine and healthcare advancements. The company's dedication to enhancing medical accuracy in infection treatment positions it as an impactful player in the rapidly evolving biotechnology and healthcare sectors.
